Long-term effects of nitrendipine on hemodynamics and oxygen transport in patients with cor pulmonale.
暂无分享,去创建一个
[1] B. Firth,et al. Independence of oxygen consumption and systemic oxygen transport in patients with either stable pulmonary hypertension or refractory left ventricular failure. , 2015, The American review of respiratory disease.
[2] A. Denjean,et al. Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine. , 2015, The American review of respiratory disease.
[3] J. Lynch,et al. The dependence of oxygen uptake on oxygen delivery in the adult respiratory distress syndrome. , 2015, The American review of respiratory disease.
[4] C. Mélot,et al. Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease. , 1984, The American review of respiratory disease.
[5] C. Keller,et al. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension. , 1984, The American review of respiratory disease.
[6] C. Kallman,et al. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study. , 1984, The American review of respiratory disease.
[7] L. Rubin,et al. Effects of oral hydralazine on gas exchange in patients with cor pulmonale. , 1983, The American journal of medicine.
[8] R. Matthay,et al. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study. , 1983, The American journal of cardiology.
[9] D. Warltier,et al. The Slow‐Channel Calcium Blocking Agent, Nitrendipine, and Coronary Collateral Blood Flow , 1983, Journal of cardiovascular pharmacology.
[10] W. Summer,et al. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. , 1982, The American journal of cardiology.
[11] B. Massie,et al. Deleterious effects of hydralazine in patients with pulmonary hypertension. , 1982, The New England journal of medicine.
[12] P. Barnes,et al. A calcium antagonist, nifedipine, modifies exercise-induced asthma. , 1981, Thorax.
[13] A. Ducoloné,et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. , 1981, Thorax.
[14] G. Simonneau,et al. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. , 1981, The New England journal of medicine.
[15] K. Patel. Calcium antagonists in exercise-induced asthma. , 1981, British medical journal.
[16] A. Loiseau,et al. Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. , 1979, Chest.
[17] B. Burrows,et al. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. , 1979, The American review of respiratory disease.
[18] B. Burrows,et al. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. , 1972, The New England journal of medicine.
[19] R. Peter,et al. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale. , 1981, The American journal of cardiology.
[20] L. Rubin,et al. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction. , 1981, The Journal of clinical investigation.
[21] E. Weitzenblum. Prognosis of pulmonary hypertension in chronic obstructive pulmonary disease. , 1980, Cor et vasa.